- Home
- EXEL vs GEN Comparison
EXEL vs GEN Comparison
Compare EXEL & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | GEN |
|---|---|---|
| Founded | 1994 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 15.5B |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EXEL | GEN |
|---|---|---|
| Price | $56.10 | $26.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 8 |
| Target Price | ★ $46.50 | $32.88 |
| AVG Volume (30 Days) | 2.5M | ★ 5.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ 57.95 | 52.43 |
| EPS | 0.79 | ★ 1.57 |
| Revenue | $452,477,000.00 | ★ $6,676,000,000.00 |
| Revenue This Year | $13.61 | $27.40 |
| Revenue Next Year | $13.13 | $5.41 |
| P/E Ratio | $70.29 | ★ $16.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.76 | $17.78 |
| 52 Week High | $57.57 | $32.22 |
Technical Indicators
Market Signals| Indicator | EXEL | GEN |
|---|---|---|
| Relative Strength Index (RSI) | 60.64 | 55.37 |
| Support Level | $40.77 | $25.94 |
| Resistance Level | $57.57 | $27.49 |
| Average True Range (ATR) | 1.41 | 0.87 |
| MACD | -0.17 | -0.00 |
| Stochastic Oscillator | 69.69 | 51.33 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.